Could Alzheimer’s treatment drugs be the next big investor opportunity after obesity pills?
The search for effective Alzheimer’s treatments is emerging as a promising market, capturing the attention of major ...
World’s largest proteins study ‘invaluable’ for understanding disease – experts
The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing how diseases develop and paving the way for simple blood tests to detect ...
Doctor who punched dementia patient tried to apologise but 'maintains innocence'
Dr Xowi Mwimbi was jailed last February after he punched a dementia patient in the face when he used a racist term, and faces ...
New dementia tool predicts when symptoms will start: ‘Would you want to know?’
Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
Florey Dementia Index: This online tool predicts age of onset for early Alzheimer’s disease
A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...
Hosted on MSN1d
Breakthrough drugs herald ‘new era’ in battle against dementia, experts predict
Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
New evidence links dementia to problems with the brain's waste clearance system
A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...
Neuroscience News2d
New Biomarker Links Brain Waste Clearance to Vascular Dementia
Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.
mcknightshomecare7d
Hospice clinicians hold doubts about use of antipsychotics, study finds
Some end-of-life clinicians are concerned about antipsychotics' effectiveness compared with other treatment options.
First pill to slow down Alzheimer’s considered for use on NHS
The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS ...
MarketWatch12d
CervoMed’s stock craters 77% after failed trial of treatment for rare brain disease
CervoMed Inc.’s stock cratered early Tuesday after the biotech company said a midstage trial of a treatment for patients with dementia with Lewy bodies, or DLB, failed to meet its main goals.
Five monumental Alzheimer’s discoveries scientists made in 2024
With an estimated 6.9 million Americans aged 65 and older currently living with Alzheimer’s disease, the road to a cure seems ...